回顾性评价NI-RADS在监测CT或MRI上检测口腔鳞状细胞癌术后复发的作用
本研究回顾性纳入158例口腔鳞状细胞癌根治性切除后进入监测项目的患者,共评估503次增强CT或MRI检查,由4名头颈影像专科放射科医师随机分配并给出原发灶和颈部NI-RADS分类(共1006个分类)。原发灶和颈部复发率分别为7.6%(38/503)和6.2%(31/503),NI-RADS对原发灶和颈部的AUC分别为0.934和0.959,阅片者间一致性分别为0.67和0.81。结论认为NI-RADS在检测口腔鳞状细胞癌原发灶和颈部复发方面具有极好的判别能力。
要点
- 原发灶NI-RADS 1类复发率1.0%,2a类7.1%,2b类5.6%,3类66.7%,4类100.0%。
- 颈部NI-RADS 1类复发率0.5%,2类7.0%,3类80.0%,4类100.0%。
- NI-RADS对原发灶和颈部的AUC分别为0.934和0.959,判别能力极好。
核心结论
- NI-RADS在检测口腔鳞状细胞癌原发灶和颈部复发方面具有极好的判别能力,AUC分别为0.934和0.959。
研究设计与样本
- 回顾性研究纳入158例口腔鳞状细胞癌根治性切除后进入机构监测项目的患者,共评估503次增强CT或MRI检查。
诊断标准与关键数值
- 原发灶复发率:NI-RADS 1类1.0%,2a类7.1%,2b类5.6%,3类66.7%,4类100.0%。
- 颈部复发率:NI-RADS 1类0.5%,2类7.0%,3类80.0%,4类100.0%。
- NI-RADS对原发灶的AUC为0.934,对颈部的AUC为0.959。
- 阅片者间一致性:原发灶Kendall W为0.67,颈部为0.81。
临床应用与阅片要点
- 放射科医师和颌面外科医师应在术后口腔鳞状细胞癌监测方案中实施NI-RADS,以通过影像以有效和标准化的方式帮助检测复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Imaging surveillance is important for the early diagnosis of recurrence after definitive treatment of oral squamous cell carcinoma (OSCC). The Neck Imaging Reporting and Data System (NI-RADS) includes a standardized template for surveillance imaging and categorizes probability of recurrence at the primary site and in the neck (cervical lymph nodes) by assigning categories of 1 (no evidence of recurrence), 2 (low suspicion, subdivided into 2a and 2b for the primary site), 3 (high suspicion), and 4 (definite recurrence). OBJECTIVE. The aim of this study was to determine the rate of locoregional and nodal OSCC recurrence stratified by NI-RADS category among patients undergoing surveillance CT or MRI. METHODS. This retrospective study included 158 patients enrolled in an institutional surveillance program after resection of OSCC with curative intent. A total of 503 contrast-enhanced CT or MRI examinations performed during surveillance were evaluated. Each examination was randomly assigned to one of four radiologists with expertise in head and neck imaging, who provided NI-RADS categories for the primary site and the neck (1006 assigned NI-RADS categories). NI-RADS performance in identifying recurrence was assessed by ROC curve analysis. All four readers evaluated 50 randomly assigned cases to determine interreader agreement by use of the Kendall W statistic. RESULTS. Cancer recurrence was confirmed in 7.6% (38/503) of cases for the primary site and in 6.2% (31/503) for the neck. For the primary site, recurrence rates were 1.0% in NI-RADS category 1, 7.1% in category 2a, 5.6% in category 2b, 66.7% in category 3, and 100.0% in category 4. For the neck, recurrence rates were 0.5% in category 1, 7.0% in category 2, 80.0% in category 3, and 100.0% in category 4. NI-RADS had AUC values of 0.934 for the primary site and 0.959 for the neck. Interreader agreement was 0.67 for the primary site and 0.81 for the neck. CONCLUSION. NI-RADS offers excellent discriminatory power in detection of OSCC recurrence, both for the primary site and the neck. CLINICAL IMPACT. Radiologists and maxillofacial surgeons should implement NI-RADS in surveillance regimens for postoperative OSCC to help detect recurrences in an effective and standardized manner using imaging.
引用
- Dinkelborg P, Ro SR, Shnayien S, et al. Retrospective Evaluation of NI-RADS for Detecting Postsurgical Recurrence of Oral Squamous Cell Carcinoma on Surveillance CT or MRI. AJR Am J Roentgenol. 2020. PMID: 32876497. doi:10.2214/AJR.20.24209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。